These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31194696)

  • 21. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory Parkinson's disease.
    Schoenberg MR; Mash KM; Bharucha KJ; Francel PC; Scott JG
    Stereotact Funct Neurosurg; 2008; 86(6):337-44. PubMed ID: 18854660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual threshold neural closed loop deep brain stimulation in Parkinson disease patients.
    Velisar A; Syrkin-Nikolau J; Blumenfeld Z; Trager MH; Afzal MF; Prabhakar V; Bronte-Stewart H
    Brain Stimul; 2019; 12(4):868-876. PubMed ID: 30833216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation-induced dyskinesia in the early stage after subthalamic deep brain stimulation.
    Zheng Z; Li Y; Li J; Zhang Y; Zhang X; Zhuang P
    Stereotact Funct Neurosurg; 2010; 88(1):29-34. PubMed ID: 19940547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.
    Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S
    Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep brain stimulation of the subthalamic nucleus and the temporal discounting of primary and secondary rewards.
    Aiello M; Terenzi D; Furlanis G; Catalan M; Manganotti P; Eleopra R; Belgrado E; Rumiati RI
    J Neurol; 2019 May; 266(5):1113-1119. PubMed ID: 30762102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Deep Brain Stimulation of the Subthalamic Nucleus Settings on Voice Quality, Intensity, and Prosody in Parkinson's Disease: Preliminary Evidence for Speech Optimization.
    Abeyesekera A; Adams S; Mancinelli C; Knowles T; Gilmore G; Delrobaei M; Jog M
    Can J Neurol Sci; 2019 May; 46(3):287-294. PubMed ID: 30905324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
    Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthalamic nucleus deep brain stimulation improves somatosensory function in Parkinson's disease.
    Aman JE; Abosch A; Bebler M; Lu CH; Konczak J
    Mov Disord; 2014 Feb; 29(2):221-8. PubMed ID: 24243788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Short Pulse Width Settings on the Therapeutic Window in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's disease.
    Dayal V; Grover T; Limousin P; Akram H; Cappon D; Candelario J; Salazar M; Tripoliti E; Zrinzo L; Hyam J; Jahanshahi M; Hariz M; Foltynie T
    J Parkinsons Dis; 2018; 8(2):273-279. PubMed ID: 29843252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel assistive method for rigidity evaluation during deep brain stimulation surgery using acceleration sensors.
    Shah A; Coste J; Lemaire JJ; Schkommodau E; Taub E; Guzman R; Derost P; Hemm S
    J Neurosurg; 2017 Sep; 127(3):602-612. PubMed ID: 27982769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
    Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreasing subthalamic deep brain stimulation frequency reverses cognitive interference during gait initiation in Parkinson's disease.
    Varriale P; Collomb-Clerc A; Van Hamme A; Perrochon A; Kemoun G; Sorrentino G; George N; Lau B; Karachi C; Welter ML
    Clin Neurophysiol; 2018 Nov; 129(11):2482-2491. PubMed ID: 30100532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dominant efficiency of nonregular patterns of subthalamic nucleus deep brain stimulation for Parkinson's disease and obsessive-compulsive disorder in a data-driven computational model.
    Karamintziou SD; Deligiannis NG; Piallat B; Polosan M; Chabardès S; David O; Stathis PG; Tagaris GA; Boviatsis EJ; Sakas DE; Polychronaki GE; Tsirogiannis GL; Nikita KS
    J Neural Eng; 2016 Feb; 13(1):016013. PubMed ID: 26695534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling parkinsonian circuitry and the DBS electrode. II. Evaluation of a computer simulation model of the basal ganglia with and without subthalamic nucleus stimulation.
    Shils JL; Mei LZ; Arle JE
    Stereotact Funct Neurosurg; 2008; 86(1):16-29. PubMed ID: 17881885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.